More Articles Back to Article
- WHO to convene emergency meeting on coronavirus cases in China
- Novartis gains EU approval for MS treatment Mayzent
- Label expansion approved in Europe for Darzalex, triple-drug combo in MM treatment
- Lymphoma treatment gains conditional approval in Europe
- FDA sends warning letter to Chinese OTC drug firm
EU clears Saladax's clozapine test
European regulators have granted CE mark approval to Saladax Biomedical's MyCare Insite Clozapine test for use in treating and monitoring patients with schizophrenia. The point-of-care assay provide accurate and precise clozapine blood levels by testing capillary blood on the MyCare Insite platform. 360Dx (tiered subscription model) (9/5)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!